Limited-stage small cell lung cancer: Local failure after chemotherapy and radiation therapy

Radiology

Volumn 208, Issue 2, 1998, Pages 511-515

  Tada, Takuhito ^a   Minakuchi, Kazuo ^a   Koda, Mayuko ^a   Masuda, Noriyuki ^a   Matsui, Kaoru ^a   Kawase, Ichiro ^a   Nakajima, Toshifumi ^b   Nishioka, Masayuki ^c   Fukuoka, Masahiro ^d   Kozuka, Takahiro ^a  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b TENRI HOSPITAL   (Japan)

^c Osaka Prefecture University   (Japan)

^d KINKI UNIVERSITY   (Japan)

Author keywords

Lung neoplasms; Lung neoplasms, therapeutic radiology; Lung neoplasms, therapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SURVIVAL TIME; TREATMENT FAILURE; TUMOR VOLUME;

EID: 0031830325     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.208.2.9680584     Document Type: Article

References (10)

1. Arriagada R, Ihde DC, Johnson DH, Perry MC, Pignon JP, Souhami RL. Meta-analysis of randomized trials evaluating the role of thoracic radiotherapy in limited small cell lung carcinoma (SCLC) (abstr). Lung Cancer 1991; 7(suppl):98.
2. Warde P, Payne D. Does thoracic irradiation improve survival of local control in limited stage small cell carcinoma of the lung? a meta-analysis. J Clin Oncol 1992; 10:890-895.
3. Bunn PA, Lichter AS, Makuch RW, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective randomized trial. Ann Intern Med 1987; 106:655-662.
4. Kies MS, Mira JG, Crowley JJ, et al. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders - a Southwest Oncology Group study. J Clin Oncol 1987; 5:592-600.
5. Takada M, Fukuoka M, Furuse M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etoposide (E) for limited-stage (LS) small cell lung cancer (SCLC): preliminary results of the Japan Clinical Oncology Group (JCOG) (abstr). Proc Am Soc Clin Oncol 1996; 15:372.
6. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655.
7. Komaki R, Shin DM, Glisson BS, et al. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1995; 31:807-811.
8. Arriagada R, Pellae-Cosset B, Guevara JCL, et al. Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiother Oncol 1991; 20:91-98.
9. Healey EA, Abner A. Thoracic and cranial radiotherapy for limited-stage small cell lung cancer. Chest 1995; 107(suppl 6): 249S-254S.
10. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995; 31:1093-1112.